- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Insurers say they were blindsided when the Biden administration announced Thursday that private insurance plans will be required to cover at-home COVID-19 tests purchased over-the-counter, and they have lots of questions, including whether Medicaid and Medicare plans also must cover the OTC tests, whether there will be guardrails against fraud and abuse, and how the government will ensure test prices are kept in check.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us